Mehmet Ozgün Ozen

The paper uses multimodal SERS and RNA-Seq to analyze plasma extracellular vesicles in T2DM patients, identifying subtype-specific molecular features and miRNA expression patterns.

This study develops Glio-SERS, a method combining SERS and AI to profile plasma extracellular vesicles in brain tumors, showing 88% accuracy in distinguishing glioblastoma and meningioma from healthy controls.

This study identifies specific extracellular RNA signatures secreted by mutant KRAS(G12C) lung adenocarcinoma cells that correlate with patient survival.

This study identifies how mutant KRAS reprograms the noncoding transcriptome, upregulating repetitive noncoding RNAs and inducing IFN-stimulated genes through epigenetic and RNA-based mechanisms.